Future studies will experimentally elucidate the precise regulatory effects of AR on the AGE-RAGE, TNF, and IL-17 signalling pathways in diabetes and its complications, thereby deepening our understanding of its efficacy and underlying mechanisms in T2DM. The gene discussed is IL17A; the disease is type 2 diabetes mellitus.